ADMA BIOLOGICS INC's ticker is ADMA and the CUSIP is 000899104. A total of 93 filers reported holding ADMA BIOLOGICS INC in Q2 2021. The put-call ratio across all filers is 5.60 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $799,525 | -11.9% | 223,331 | -9.2% | 0.00% | 0.0% |
Q2 2023 | $907,913 | +9.7% | 246,047 | -1.6% | 0.00% | 0.0% |
Q1 2023 | $827,526 | -12.6% | 250,008 | +2.4% | 0.00% | 0.0% |
Q4 2022 | $947,205 | +432.1% | 244,125 | +232.8% | 0.00% | – |
Q3 2022 | $178,000 | +13.4% | 73,360 | -7.7% | 0.00% | – |
Q2 2022 | $157,000 | -10.3% | 79,475 | -20.3% | 0.00% | – |
Q1 2021 | $175,000 | -9.8% | 99,682 | 0.0% | 0.00% | – |
Q4 2020 | $194,000 | -10.6% | 99,682 | +9.8% | 0.00% | – |
Q3 2020 | $217,000 | -18.4% | 90,748 | 0.0% | 0.00% | – |
Q2 2020 | $266,000 | -13.6% | 90,748 | -15.0% | 0.00% | -100.0% |
Q1 2020 | $308,000 | -1.9% | 106,801 | +36.2% | 0.00% | 0.0% |
Q4 2019 | $314,000 | -10.0% | 78,426 | 0.0% | 0.00% | 0.0% |
Q3 2019 | $349,000 | +114.1% | 78,426 | +86.3% | 0.00% | – |
Q2 2019 | $163,000 | +39.3% | 42,093 | +36.1% | 0.00% | – |
Q1 2019 | $117,000 | +58.1% | 30,927 | 0.0% | 0.00% | – |
Q4 2018 | $74,000 | -58.9% | 30,927 | +6.8% | 0.00% | – |
Q3 2018 | $180,000 | +37.4% | 28,946 | 0.0% | 0.00% | – |
Q2 2018 | $131,000 | – | 28,946 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Biomark Capital Management Co. LLC | 1,433,304 | $6,464,000 | 99.88% |
Broadfin Capital, LLC | 3,249,829 | $14,657,000 | 2.31% |
Stonepine Capital Management, LLC | 831,731 | $3,751,000 | 2.28% |
Aisling Capital LLC | 3,608,171 | $16,273,000 | 2.14% |
Consonance Capital Management LP | 4,249,234 | $19,164,000 | 1.24% |
MORGENS WATERFALL VINTIADIS & CO INC | 375,000 | $1,691,000 | 1.20% |
Perceptive Advisors | 6,521,102 | $29,410,000 | 0.77% |
PURA VIDA INVESTMENTS, LLC | 325,000 | $1,466,000 | 0.59% |
683 Capital Management, LLC | 885,000 | $3,991,000 | 0.27% |
ARDSLEY ADVISORY PARTNERS LP | 80,000 | $361,000 | 0.05% |